Patients fear losing access to affordable weight loss drugs amid FDA crackdown 02:55. CHARLESTON, S.C. — When Page Campbell's doctor recommended that she try an injectable prescription drug ...

The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects.

But at the moment, in America, relatively few insurance policies cover Wegovy—mainly those backed by employers. (This still leaves Wegovy a potential American market of 40m patients, notes Lars ...

Administration officials reversed a decision made during the Biden presidency that would have given millions of people access to weight-loss drugs paid for Medicare and Medicaid. By Margot Sanger ...

A survey of employers finds that only about a fifth of large companies cover drugs like Wegovy for weight loss. A majority of companies that do cover the medicines have requirements.

While employers typically cover the medications for diabetes, fewer of them do so for weight loss, in part because of the drugs’ high prices — which have also limited Americans’ access to them.

The good news is that when you’re eligible to enroll in Medicare, you’ll also be eligible to buy insurance that pays some of the costs of your prescription drugs —… The good news is that ...

But commercial plans apply access restrictions to just 35% of the drugs they cover. The percentage of covered drugs subject to access restrictions is 49% at Medicare plans and 63% at Medicaid plans.

North Carolina is not the first state to cover GLP-1 drugs in Medicaid, but others have done so more tentatively, often establishing complicated rules and barriers to care.